0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Involvement of DKK1 secreted from adipose‐derived stem cells in alopecia areata

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Adipose‐derived stem cells (ASCs) have shown efficacy in promoting hair growth, while DKK1 inhibits the WNT pathway, which is associated with hair loss. Our study focused on investigating the expression of DKK1 in alopecia areata (AA), a condition characterised by significant increases in the DKK1 levels in human and mouse ASCs. Treatment of interferon‐γ increased the expression of DKK1 via STAT3 phosphorylation in ASCs. Treatment with recombinant DKK1 resulted in a decrease of cell growth in outer root sheath cells, whereas the use of a DKK1 neutralising antibody promoted hair growth. These results indicate that ASCs secrete DKK1, playing a crucial role in the progression and development of AA. Consequently, we generated DKK1 knockout (KO) ASCs using the Crispr/Cas9 system and evaluated their hair growth‐promoting effects in an AA model. The DKK1 KO in ASCs led to enhanced cell motility and reduced cellular senescence by activating the WNT signalling pathway, while it reduced the expression of inflammatory cytokines by inactivating the NF‐kB pathway. As expected, the intravenous injection of DKK1‐KO‐ASCs in AA mice, and the treatment with a conditioned medium derived from DKK1‐KO‐ASCs in hair organ culture proved to be more effective compared with the use of naïve ASCs and their conditioned medium. Overall, these findings suggest that DKK1 represents a novel therapeutic target for treating AA, and cell therapy using DKK1‐KO‐ASCs demonstrates greater efficiency.

          Abstract

          IFNγ stimulates an increase in DKK1 levels in adipose‐derived stem cells (ASCs) through the activation of the STAT3 pathway. The secreted DKK1 promotes inflammation and inhibits follicular growth. However, when DKK1 is knocked out in ASCs, it deactivates the NF‐kB pathway, resulting in reduced cytokine levels and suppression of the inflammatory response. Moreover, DKK1 knockout ASCs (DKK1‐KO‐ASCs) activate the Wnt pathway, enhancing the growth and migration abilities of the DKK1‐KO‐ASCs and reducing cellular senescence. As a result, DKK1‐KO‐ASCs exhibit an inhibitory effect on alopecia areata.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: found
          • Article: not found

          Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells.

          The delivery of autologous cells to increase angiogenesis is emerging as a treatment option for patients with cardiovascular disease but may be limited by the accessibility of sufficient cell numbers. The beneficial effects of delivered cells appear to be related to their pluripotency and ability to secrete growth factors. We examined nonadipocyte stromal cells from human subcutaneous fat as a novel source of therapeutic cells. Adipose stromal cells (ASCs) were isolated from human subcutaneous adipose tissue and characterized by flow cytometry. ASCs secreted 1203+/-254 pg of vascular endothelial growth factor (VEGF) per 10(6) cells, 12 280+/-2944 pg of hepatocyte growth factor per 10(6) cells, and 1247+/-346 pg of transforming growth factor-beta per 10(6) cells. When ASCs were cultured in hypoxic conditions, VEGF secretion increased 5-fold to 5980+/-1066 pg/10(6) cells (P=0.0016). The secretion of VEGF could also be augmented 200-fold by transfection of ASCs with a plasmid encoding VEGF (P<0.05). Conditioned media obtained from hypoxic ASCs significantly increased endothelial cell growth (P<0.001) and reduced endothelial cell apoptosis (P<0.05). Nude mice with ischemic hindlimbs demonstrated marked perfusion improvement when treated with human ASCs (P<0.05). Our experiments delineate the angiogenic and antiapoptotic potential of easily accessible subcutaneous adipose stromal cells by demonstrating the secretion of multiple potentially synergistic proangiogenic growth factors. These findings suggest that autologous delivery of either native or transduced subcutaneous ASCs, which are regulated by hypoxia, may be a novel therapeutic option to enhance angiogenesis or achieve cardiovascular protection.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6.

            Dickkopf-1 (Dkk-1) is a head inducer secreted from the vertebrate head organizer and induces anterior development by antagonizing Wnt signaling. Although several families of secreted antagonists have been shown to inhibit Wnt signal transduction by binding to Wnt, the molecular mechanism of Dkk-1 action is unknown. The Wnt family of secreted growth factors initiates signaling via the Frizzled (Fz) receptor and its candidate coreceptor, LDL receptor-related protein 6 (LRP6), presumably through Fz-LRP6 complex formation induced by Wnt. The significance of the Fz-LRP6 complex in signal transduction remains to be established. We report that Dkk-1 is a high-affinity ligand for LRP6 and inhibits Wnt signaling by preventing Fz-LRP6 complex formation induced by Wnt. Dkk-1 binds neither Wnt nor Fz, nor does it affect Wnt-Fz interaction. Dkk-1 function in head induction and Wnt signaling inhibition strictly correlates with its ability to bind LRP6 and to disrupt the Fz-LRP6 association. LRP6 function and Dkk-1 inhibition appear to be specific for the Wnt/Fz beta-catenin pathway. Our results demonstrate that Dkk-1 is an LRP6 ligand and inhibits Wnt signaling by blocking Wnt-induced Fz-LRP6 complex formation. Our findings thus reveal a novel mechanism for Wnt signal modulation. LRP6 is a Wnt coreceptor that appears to specify Wnt/Fz signaling to the beta-catenin pathway, and Dkk-1, distinct from Wnt binding antagonists, may be a specific inhibitor for Wnt/beta-catenin signaling. Our findings suggest that Wnt-Fz-LRP6 complex formation, but not Wnt-Fz interaction, triggers Wnt/beta-catenin signaling.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Role of adipose-derived stem cells in wound healing.

              Impaired wound healing remains a challenge to date and causes debilitating effects with tremendous suffering. Recent advances in tissue engineering approaches in the area of cell therapy have provided promising treatment options to meet the challenges of impaired skin wound healing such as diabetic foot ulcers. Over the last few years, stem cell therapy has emerged as a novel therapeutic approach for various diseases including wound repair and tissue regeneration. Several different types of stem cells have been studied in both preclinical and clinical settings such as bone marrow-derived stem cells, adipose-derived stem cells (ASCs), circulating angiogenic cells (e.g., endothelial progenitor cells), human dermal fibroblasts, and keratinocytes for wound healing. Adipose tissue is an abundant source of mesenchymal stem cells, which have shown an improved outcome in wound healing studies. ASCs are pluripotent stem cells with the ability to differentiate into different lineages and to secrete paracrine factors initiating tissue regeneration process. The abundant supply of fat tissue, ease of isolation, extensive proliferative capacities ex vivo, and their ability to secrete pro-angiogenic growth factors make them an ideal cell type to use in therapies for the treatment of nonhealing wounds. In this review, we look at the pathogenesis of chronic wounds, role of stem cells in wound healing, and more specifically look at the role of ASCs, their mechanism of action and their safety profile in wound repair and tissue regeneration. © 2014 by the Wound Healing Society.
                Bookmark

                Author and article information

                Contributors
                brian99@empal.com , brian99@yonsei.ac.kr
                Journal
                Cell Prolif
                Cell Prolif
                10.1111/(ISSN)1365-2184
                CPR
                Cell Proliferation
                John Wiley and Sons Inc. (Hoboken )
                0960-7722
                1365-2184
                22 November 2023
                March 2024
                : 57
                : 3 ( doiID: 10.1111/cpr.v57.3 )
                : e13562
                Affiliations
                [ 1 ] Epi Biotech Co., Ltd. Incheon South Korea
                [ 2 ] College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences Yonsei University Incheon South Korea
                [ 3 ] New Hair Plastic Surgery Clinic Seoul South Korea
                [ 4 ] Institute for Human Tissue Restoration, Department of Plastic and Reconstructive Surgery Yonsei University College of Medicine Seoul South Korea
                Author notes
                [*] [* ] Correspondence

                Jong‐Hyuk Sung, College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahakro, Yeonsu‐gu, Incheon 21983, South Korea.

                Email: brian99@ 123456empal.com and brian99@ 123456yonsei.ac.kr

                Author information
                https://orcid.org/0000-0002-8084-9017
                https://orcid.org/0009-0006-8057-2237
                https://orcid.org/0000-0003-4261-1451
                https://orcid.org/0000-0002-9284-052X
                https://orcid.org/0000-0002-3145-7463
                https://orcid.org/0000-0002-3334-3398
                Article
                CPR13562
                10.1111/cpr.13562
                10905327
                37991164
                99105292-2ea1-4134-a69a-d6b1eb82908c
                © 2023 The Authors. Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 11 September 2023
                : 04 July 2023
                : 10 October 2023
                Page count
                Figures: 7, Tables: 0, Pages: 15, Words: 9000
                Funding
                Funded by: Korean Fund for Regenerative Medicine funded by Ministry of Science and ICT, and Ministry of Health and Welfare , doi 10.13039/501100014188;
                Award ID: 23C0125L1
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                March 2024
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.8 mode:remove_FC converted:01.03.2024

                Cell biology
                Cell biology

                Comments

                Comment on this article